References
- Latif R, Morshed SA, Zaidi M, Davies TF. The thyroid-stimulating hormone receptor: Impact of thyroid-stimulating hormone and thyroid-stimulating hormone receptor antibodies on multimerization, cleavage, and signaling. Endocrinol Metabol Clin N Amer. 2009; 38 2: 319–341.
- Lupsa BC, Chong AY, Cochran EK, Soos MA, Semple RK, Gorden P. Autoimmune forms of hypoglycemia. Medicine (Baltimore). 2009; 88 3: 141–153.
- Petz LD. Cold antibody autoimmune hemolytic anemias. Blood Rev. 2008; 22 1: 1–15.
- Verschuuren JJ, Palace J, Gilhus NE. Clinical aspects explained. Autoimmunity. 2010; 43 5: 344–352.
- Gomez J, Van den Broeck J, Vrolix K, Janssen SP, Lemmens MA, van der Esch E, Duimel H, Frederik P, Molenaar PC, Martínez-Martínez P, De Baets MH, Losen M. Antibody effector mechanisms in myasthenia gravis – Pathogenesis at the neuromuscular junction. Autoimmunity. 2010; 43 5: 353–370.
- Lindstrom JM, Seybold ME, Lennon VA, Whittingham S, Duane DD. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology. 1976; 26 11: 1054–1059.
- Leite MI, Waters P, Vincent A. Diagnostic use of auto-antibodies in myasthenia gravis. Autoimmunity. 2010; 43 5: 371–379.
- Vrolix K, Fraussen J, Molenaar PC, Losen M, Somers V, Stinissen P, De Baets MH, Martínez-Martínez P. The auto-antigen repertoire in myasthenia gravis. Autoimmunity. 2010; 43 5: 380–400.
- Le Panse R, Bismuth J, Cizeron-Clairac G, Weiss JM, Cufi P, Dartevelle P, Kerlero de Rosbo N, Berrih-Aknin S. Thymic remodeling associated with hyperplasia in myasthenia gravis. Autoimmunity. 2010; 43 5: 401–412.
- Marx A, Willcox N, Leite MI, Chuang W, Schalke B, Nix W, Ströbel P. Thymoma and paraneoplastic myasthenia gravis. Autoimmunity. 2010; 43 5: 413–427.
- Sanders DB, Evoli A. Immunosuppressive therapies in myasthenia gravis. Autoimmunity. 2010; 43 5: 428–435.
- Lagoumintzis G, Zisimopoulou P, Kordas G, Lazaridis K, Poulas K, Tzartos SJ. Recent approaches to the development of antigen-specific immunotherapies for myasthenia gravis. Autoimmunity. 2010; 43 5: 436–445.
- Souroujon MC, Brenner T, Fuchs S. Development of novel therapies for MG: Studies in animal models. Autoimmunity. 2010; 43 5: 446–460.